Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -43.75%509.86M | -52.05%431.57M | -53.98%453.1M | 9.04%3.61B | -26.89%817.61M | 41.97%906.46M | -14.80%900.03M | 98.39%984.47M | 100.37%3.31B | 163.77%1.12B |
| Cost of revenue | -9.11%3.18B | 142.81%3.5B | ||||||||
| Gross profit | 332.47%431.79M | -187.53%-185.74M | ||||||||
| Operating expense | 195.56%4.33M | 11.80%341.15M | 62.04%-4.53M | 60.82%305.14M | ||||||
| Selling and administrative expenses | ---- | ---- | ---- | 25.97%273.11M | ---- | ---- | ---- | ---- | 23.44%216.8M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | -61.88%1.12M | ---- | ---- | ---- | ---- | 30.00%2.93M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 27.17%271.99M | ---- | ---- | ---- | ---- | 23.36%213.88M | ---- |
| Other operating expenses | ---- | ---- | --4.33M | -14.54%79.77M | ---- | ---- | ---- | ---- | 388.25%93.33M | ---- |
| Total other operating income | ---- | -55.12%12.76M | -195.56%-4.33M | 134.66%11.72M | 200.09%16.69M | ---- | --28.43M | -62.04%4.53M | -0.24%4.99M | --5.56M |
| Operating profit | 52.35%31.65M | -83.39%13.14M | -54.62%448.77M | 118.46%90.64M | -145.30%-26.73M | 120.73%20.77M | 120.53%79.1M | 94.62%989M | -2,284.24%-490.89M | 99.13%-10.9M |
| Net non-operating interest income (expenses) | 23.88%-2.69M | -392.90%-7.22M | -3.30%-3.54M | -118.24%-1.47M | ||||||
| Non-operating interest income | ---- | ---- | ---- | -24.16%10.56M | ---- | ---- | ---- | ---- | -37.36%13.92M | ---- |
| Non-operating interest expense | -37.22%3.02M | -40.80%2.8M | -23.88%2.69M | 15.56%17.78M | -3.29%4.7M | 28.85%4.82M | 40.53%4.73M | 3.30%3.54M | 8.46%15.38M | 40.91%4.86M |
| Net investment income | -32.33%6.13M | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | 32.78M | 0 | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 123.03%7.07M | -5.57%3.17M | ||||||||
| Income before tax | 79.37%28.62M | -86.10%10.34M | 16.16%12.67M | 125.52%123.27M | 264.92%22.03M | 115.35%15.96M | 119.13%74.37M | 208.48%10.91M | -1,133.62%-483.05M | -4.64%6.04M |
| Income tax | -39.11%425K | -29.07%283K | -10.66%436K | 96.15%2.24M | 657K | -38.83%698K | 19,850.00%399K | 488K | 105.47%1.14M | 0 |
| Net income | 84.79%28.2M | -86.41%10.06M | 17.41%12.24M | 125.00%121.03M | 254.03%21.37M | 114.52%15.26M | 119.03%73.97M | 194.68%10.42M | -815.86%-484.2M | -77.76%6.04M |
| Net income continuous operations | 84.79%28.2M | -86.41%10.06M | 17.41%12.24M | 125.00%121.03M | 254.03%21.37M | 114.52%15.26M | 119.03%73.97M | 194.68%10.42M | -815.86%-484.2M | -77.76%6.04M |
| Noncontrolling interests | 0 | 0 | 0 | 400.00%30K | 93.88%-9K | -111.48%-14K | 253.33%53K | 0 | 92.59%-10K | -1,733.33%-147K |
| Net income attributable to the company | 84.62%28.2M | -86.40%10.06M | 17.41%12.24M | 124.99%121M | 245.76%21.38M | 114.52%15.27M | 119.02%73.92M | 194.68%10.42M | -814.42%-484.19M | -77.21%6.18M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 84.62%28.2M | -86.40%10.06M | 17.41%12.24M | 124.99%121M | 245.76%21.38M | 114.52%15.27M | 119.02%73.92M | 194.68%10.42M | -814.42%-484.19M | -77.21%6.18M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 80.00%0.018 | -86.96%0.006 | 14.29%0.008 | 124.98%0.0756 | 225.00%0.013 | 115.15%0.01 | 118.93%0.046 | 250.00%0.007 | -813.68%-0.3026 | -77.01%0.004 |
| Diluted earnings per share | 80.00%0.018 | -86.96%0.006 | 14.29%0.008 | 124.98%0.0756 | 225.00%0.013 | 115.15%0.01 | 118.93%0.046 | 250.00%0.007 | -813.68%-0.3026 | -77.01%0.004 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.015 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.